Risk of triple-class virological failure in children with HIV: A retrospective cohort study

The Lancet

Volumn 377, Issue 9777, 2011, Pages 1580-1587

  Judd, Ali ^a,b   Castro, Hannah ^b   Gibb, Diana M ^b   Butler, Karina ^b   Lodwick, Rebecca K ^b   van Sighem, Ard ^f   Ramos, Jose T ^e   Warsawski, Josiane ^b   Thorne, Claire ^b   Noguera Julian, Antoni ^b   Obel, Niels ^b   Costagliola, Dominique ^b   Tookey, Pat A ^b   Colin, Céline ^b   Kjaer, Jesper ^b   Grarup, Jesper ⁱ   Chene, Genevieve ^j   Phillips, Andrew ^b   Antinori, Andrea ^b   Castagna, Antonella ^b   Cozzi Lepri, Alessandro ^b   De Luca, Andrea ^b   De Wit, Stephane ^b   Dorrucci, Maria ^b   Duval, Xavier ^b   García, Federico ^c   Ghosn, Jade ^b   Günthard, Huldrych ^b   Ledergerber, Bruno ^b   Caputo, Sergio Lo ^d   Masquelier, Bernard ^b   Meyer, Laurence ^b   Mocroft, Amanda ^b   Mussini, Cristina ^b   Paraskevis, Dimitrios ^b   Paredes, Roger ^b   Pérez Hoyos, Santiago ^b   Pillay, Deenan ^b   Podzamczer, Daniel ^b   Reiss, Peter ^f   Stephan, Christoph ^g   Teira, Ramón ^b   Torti, Carlo ^d   Touloumi, Giota ^b   Zangerle, Robert ^b   Warszawski, Josiane ^b   Dabis, François ^b   Krause, Murielle Mary ^b   Leport, Catherine ^b   de Wolf, Frank ^f   Prins, Maria ^b   Bücher, Heiner C ^b   Sabin, Caroline ^b   Fätkenheuer, Gerd ^b   Del Amo, Julia ^b   Kirk, Ole ^b   Monforte, Antonella D'Arminio ^b   Tovo, Pier Angelo ^b   de Martino, Maurizio ^b   Brockmeyer, Norbert H ^b   Battegay, Manuel ^b   Francioli, Patrick ^b   Carnicer Pont, Dolors ^b   Casabona, Jordi ^b   Miró, Jose M ^b   Goetghebuer, Tessa ^b   Garrido, Myriam ^b   Dedes, Nikos ^b   Weller, Ian ^h   Collin Filleul, Fideline ^b   Schwimmer, Christine ^b   Ellefson, Michelle ^b   Paulsen, Maria ^b   Bohlius, Julia ^b   Bouteloup, Vincent ^b   Egger, Matthias ^b   Furrer, Hansjakob ^b   Lambotte, Olivier ^b   Lewden, Charlotte ^b   Matheron, Sophie ^b   Puoti, Massimo ^b   Reekie, Joanne ^b   Smit, Colette ^b   Sterne, Jonathan ^b   Thiebaut, Rodolphe ^b   Wittkop, Linda ^b   more..

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b ICC ^*

^c San Raff aele Cohort ^*

^d The Italian Master Cohort   (Italy)

^e Madrid Cohort   (Spain)

^f ATHENA

^g HIV cohort Frankfurt   (Germany)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UPMC Univ Paris 06   (Denmark)

^j Bordeaux Regional Co ordinating Center

more..

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; AGED; ARTICLE; CHILD; CHILDHOOD DISEASE; DRUG TREATMENT FAILURE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PERINATAL INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; TRIPLE CLASS VIROLOGICAL FAILURE; VIRUS LOAD;

EID: 79955687620     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60208-0     Document Type: Article

References (34)

1. A Judd, K Doerholt, PA Tookey for the Collaborative HIV Paediatric Study (CHIPS) and National Study of HIV in Pregnancy and Childhood (NSHPC) Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care Clin Infect Dis 45 2007 918 924 (Pubitemid 47580389)
2. MT Brady, JM Oleske, PL Williams for the Pediatric AIDS Clinical Trials Group 219/219C Team Declines in mortality rates and changes in causes of death in HIV-1 infected children during the HAART era J Acquir Immune Defic Syndr 53 2010 86 94
3. M deMartino, PA Tovo, M Balducci for the Italian Register for HIV Infection in Children and the Italian National AIDS Registry Reduction in mortality with availability of antiretroviral therapy for children with perinatal infection JAMA 284 2000 190 197 (Pubitemid 30460862)
4. M Sharland, S Blanche, G Castelli, J Ramos, DM Gibb for the PENTA Steering Committee PENTA guidelines for the use of antiretroviral therapy 2004 HIV Med 5 suppl 2 2004 61 86 (Pubitemid 39077128)
5. A Violari, MF Cotton, DM Gibb Early antiretroviral therapy and mortality among HIV-infected infants N Engl J Med 359 2008 2233 2244
6. T Goetghebuer, E Haelterman, J Le Chenadec Effect of early antiretroviral therapy on the risk of AIDS/death in HIV infected infants: the European Infant Collaborative Study AIDS 23 2009 597 604
7. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children Guidelines for the use of antiretroviral agents in pediatric HIV infection. Feb 23, 2009; pp 1-139 http://aidsinfo.nih.gov/ ContentFiles/PediatricGuidelines.pdf (accessed April 21, 2010).
8. S Welch, M Sharland, EG Lyall PENTA Steering Committee PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection HIV Med 10 2009 591 613
9. WHO Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Recommendations for a public health approach http://www.who.int/hiv/pub/paediatric/infants2010/en/index.html 2010 (accessed Aug 12, 2010).
10. DL Paterson, S Swindells, J Mohr Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 133 2000 21 30 (Pubitemid 30432540)
11. JB Nachega, M Hislop, DW Dowdy, RE Chaisson, L Regensberg, G Maartens Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes Ann Intern Med 146 2007 564 573 (Pubitemid 351650537)
12. DR Bangsberg, DL Kroetz, SG Deeks Adherence-resistance relationships to combination HIV antiretroviral therapy Curr HIV/AIDS Rep 4 2007 65 72 (Pubitemid 46806622)
13. SG Deeks Determinants of virological response to antiretroviral therapy: implications for long-term strategies Clin Infect Dis 30 suppl 2 2000 177 184
14. C Reddington, J Cohen, A Baldillo Adherence to medication regimens among children with human immunodeficiency virus infection Pediatr Infect Dis 19 2000 1148 1153 (Pubitemid 32003357)
15. S Martin, DK Elliott-DeSorbo, PL Wolters Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents Pediatr Infect Dis 26 2007 61 67 (Pubitemid 46045754)
16. DA Murphy, M Belzer, SJ Durako, M Sarr, CM Wilson, LR Muenz Adolescent Medicine HIV/AIDS Research Network. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus Arch Pediatr Adolesc Med 159 2005 764 770 (Pubitemid 41126841)
17. EN Menson, AS Walker, M Sharland for the Collaborative HIV Paediatric Study Steering Committee Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study BMJ 332 2006 1183 1187
18. American Academy of Pediatrics Committee on Pediatric AIDS Section on International Child Health PL Havens, DM Gibb Increasing antiretroviral drug access for children with HIV infection Pediatrics 119 2007 838 845
19. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group Response to combination antiretroviral therapy: variation by age AIDS 22 2008 1463 1473
20. The Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years Arch Intern Med 170 2010 410 419
21. J Kjaer, B Ledergerber HIV cohort collaborations: proposal for harmonization of data exchange Antivir Ther 9 2004 631 633 (Pubitemid 39150221)
22. AS Walker, K Doerholt, M Sharland, DM Gibb for the Collaborative HIV Paediatric Study (CHIPS) Steering Committee Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study AIDS 18 2004 1915 1924 (Pubitemid 39313207)
23. VA Johnson, F Brun-Vezinet, B Clotet Update of the Drug Resistance Mutations in HIV-1 Top HIV Med 16 2008 138 145
24. Lee KJ, Lyall H, Walker AS, Sharland M, Judd A, Gibb DM. Wide disparity in switch to second-line therapy in HIV infected children in CHIPS. Eighth International Congress in Drug Therapy in HIV Infection; Glasgow, UK; Nov 12-16, 2006. PL2.4 (abstr).
25. Butler L, Bain Brickely D, Chan J, Kennedy G, Rutherford G. Rates and determinants of adherence to antiretroviral therapy (ART) in infants, children and adolescents: a systematic review. XVIII International AIDS Conference; Vienna, Austria; July 18-23, 2010. MOAB0205 (abstr).
26. A Kekitiinwa, KJ Lee, AS Walker Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland J Acquir Immune Defic Syndr Hum Retrovirol 49 2008 384 392
27. C Giaquinto, E Morelli, F Fregonese Current and future antiretroviral treatment options in paediatric HIV infection Clin Drug Investig 28 2008 375 397 (Pubitemid 351695404)
28. Melvin A, on behalf of the PENPACT-1 Study Team. PENPACT-1 (PENTA 9/PACTG 390): A randomised trial of protease inhibitor (PI) vs non-nucleoside reverse transcriptase inhibitor (NNRTI) combination antiretroviral (ART) regimens and viral load (VL) treatment switching strategies in HIV-1-infected ART-naive children age >30 days and <18 years. XVIII International AIDS Conference; Vienna, Austria; July 18-23, 2010. THLBB104 (abstr).
29. Paediatric European Network for Treatment of AIDS (PENTA) HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA) AIDS 12 1998 1 8 (abstr).
30. The PLATO II Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group; Drug resistance associated mutations in patients who during the course of treatment develop virological failure to the three original classes of antiretroviral drugs. European AIDS Clinical Society Conference; Cologne, Germany; Nov 11-14, 2009. PE 3.5/5 (abstr).
31. PENPACT-1 (PENTA 9/PACTG 390) Study Team First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial Lancet Infect Dis 2011 10.1016/S1473-3099(10)70313-3 published online Jan 31.
32. Boyd K, Walker AS, Dunn DT et al. The prevalence of darunavir associated mutations in PI-naïve and pi-experienced HIV-1 Infected children in the uk. CROI; San Francisco, USA; Feb 16-19, 2010. 851 (abstr).
33. EJ Mills, JB Nachega, I Buchan Adherence to antiretroviral therapy in sub-Saharan Africa and North America - a meta-analysis JAMA 296 2006 679 690 (Pubitemid 44200639)
34. B Ledergerber, JD Lundgren, AS Walker PLATO Collaboration Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes Lancet 364 2004 51 62